Coumarin derivatives useful as TNFα inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S302000, C548S187000

Reexamination Certificate

active

07026491

ABSTRACT:
Novel compounds composition capable of inhibiting TNFα and having antiimmunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.

REFERENCES:
patent: 3259635 (1966-07-01), Ritter et al.
patent: 522 631 (1972-06-01), None
patent: 0 171 645 (1986-02-01), None
patent: 0 428 939 (1991-05-01), None
patent: WO 92 11383 (1992-07-01), None
patent: WO 99 15523 (1999-04-01), None
Beutler, et al., Science, Oct. 1986, 470-474, vol. 234.
Grilli, et al., International Review of Cytology, (1993), 1-63, vol. 143.
Pisetsky, The New England Journal of Medicine, Mar. 2000, 810-811,vol. 342, No. 11.
Shohami et al., Journal of Cerebral Blood Flow and Metabolism, (1994), 615-619, vol. 14, No. 4.
Van Dullemen, et al., Gastroenterology (1995), 129-135, vol. 109, No. 1.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Coumarin derivatives useful as TNFα inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coumarin derivatives useful as TNFα inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coumarin derivatives useful as TNFα inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3557119

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.